Paper40757154
Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers.
Alarcon JF and 8 others. RSC Adv, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers. Papers, record 40757154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40757154
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36312688 | Overview of Methotrexate Toxicity: A Comprehensive Literature Review. | Cureus | 2022 | https://conductscience.org/library/papers/36312688 | PubMed |
| 2 | 30700021 | Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/30700021 | PubMed |
| 3 | 27865609 | Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application. | J Pharm Sci | 2017 | https://conductscience.org/library/papers/27865609 | PubMed |
| 4 | 19132915 | IL-17 and Th17 Cells. | Annu Rev Immunol | 2009 | https://conductscience.org/library/papers/19132915 | PubMed |
| 5 | 9229573 | NSAIDs, gastrointestinal injury, and cytoprotection. | Gastroenterol Clin North Am | 1996 | https://conductscience.org/library/papers/9229573 | PubMed |
| 6 | 29600391 | Safety and Antioxidant Efficacy Profiles of Rutin-Loaded Ethosomes for Topical Application. | AAPS PharmSciTech | 2018 | https://conductscience.org/library/papers/29600391 | PubMed |
| 7 | 21665123 | Seronegative spondyloarthritis. | Best Pract Res Clin Rheumatol | 2010 | https://conductscience.org/library/papers/21665123 | PubMed |
| 8 | 30410704 | Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. | Nano Rev Exp | 2017 | https://conductscience.org/library/papers/30410704 | PubMed |
| 9 | 20193005 | Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. | Immunol Rev | 2010 | https://conductscience.org/library/papers/20193005 | PubMed |
| 10 | 27199229 | Ethosomes and Transfersomes: Principles, Perspectives and Practices. | Curr Drug Deliv | 2017 | https://conductscience.org/library/papers/27199229 | PubMed |
| 11 | 26872084 | Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis. | Clinics (Sao Paulo) | 2016 | https://conductscience.org/library/papers/26872084 | PubMed |
| 12 | 35735679 | Fabrication of Ethosomes Containing Tocopherol Acetate to Enhance Transdermal Permeation: In Vitro and Ex Vivo Characterizations. | Gels | 2022 | https://conductscience.org/library/papers/35735679 | PubMed |
| 13 | 27571096 | Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes. | Pharmaceutics | 2016 | https://conductscience.org/library/papers/27571096 | PubMed |
| 14 | 26924445 | Nanoemulsions: formation, properties and applications. | Soft Matter | 2016 | https://conductscience.org/library/papers/26924445 | PubMed |
| 15 | 18654426 | Nanocarriers as an emerging platform for cancer therapy. | Nat Nanotechnol | 2007 | https://conductscience.org/library/papers/18654426 | PubMed |
| 16 | 36499432 | Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499432 | PubMed |
| 17 | 12847701 | Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. | Arthritis Rheum | 2003 | https://conductscience.org/library/papers/12847701 | PubMed |
| 18 | 28324579 | Nanoemulsion: an advanced mode of drug delivery system. | 3 Biotech | 2015 | https://conductscience.org/library/papers/28324579 | PubMed |
| 19 | 32066146 | Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. | Ann Intern Med | 2020 | https://conductscience.org/library/papers/32066146 | PubMed |
| 20 | 39560334 | Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward. | Nanoscale | 2024 | https://conductscience.org/library/papers/39560334 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942845 | The Application Potential and Future Challenges of Plant-Derived Exosome-like Nanoparticles in the Treatment of Liver Diseases. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942845 | PubMed |
| 42768197 | Design and development of piperine-loaded polymeric micellar gel for the management of rheumatoid arthritis. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42768197 | PubMed |
| 42544244 | Theranostic Nanoprobes for Rheumatoid Arthritis: From Inflammation Visualization to Guided Precision Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42544244 | PubMed |
| 41978717 | Bridging Pharmacology and Nanotechnology: Mechanistic Insights into Traditional Chinese Medicine-Based Nanodelivery Systems for Rheumatoid Arthritis. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41978717 | PubMed |
| 41939210 | Advancing Arthritis Therapy: The Frontier of Targeted and Responsive Nanomedicine. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41939210 | PubMed |
| 41142242 | Nanotechnology-driven synergy in cardio-oncology: enhancing tumor suppression and reducing cardiotoxicity. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41142242 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40757154
GET https://conductscience.org/api/papers/v1/40757154/references?page=2